Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Bhor · SciRah

Researcher profile · Semantic Scholar

M. Bhor

Share profile

M. Bhor — researcher profile on SciRah

h-index: 15
Works: 79
Citations: 904

Most-cited papers

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
N. Denduluri, D. Patt, Yunfei Wang, M. Bhor +9 more
2015The Journal of the National Comprehensive Cancer Network134 citations Open access
Semantic Scholar
Sickle cell disease complications: Prevalence and resource utilization
N. Shah, M. Bhor, Lin Xie, J. Paulose +1 more
2019bioRxiv100 citations Open access
Semantic Scholar
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer
N. Denduluri, G. Lyman, Yunfei Wang, P. K. Morrow +11 more
2018Clinical Breast Cancer83 citations Open access
Semantic Scholar
The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
Avery A. Rizio, M. Bhor, Xiaochen Lin, K. McCausland +5 more
2020Quality of Life Research66 citations Open access
Semantic Scholar
Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
N. Shah, M. Bhor, Lin Xie, R. Halloway +3 more
2019Health and Quality of Life Outcomes65 citations Open access
Semantic Scholar
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices.
G. Sonpavde, M. Bhor, D. Hennessy, D. Bhowmik +5 more
2015Clinical Genitourinary Cancer50 citations Open access
Semantic Scholar
Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study
N. Shah, M. Bhor, Lin Xie, J. Paulose +1 more
2020Journal of health economics and outcomes research40 citations Open access
Semantic Scholar
Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review
Soyon Lee, Diana K. Vania, M. Bhor, D. Revicki +2 more
2020International Journal of General Medicine35 citations Open access
Semantic Scholar
Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
N. Shah, M. Bhor, Lin Xie, S. Arcona +3 more
2019Journal of health economics and outcomes research35 citations Open access
Semantic Scholar
Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance – the perspective of private and public payers
N. Shah, M. Bhor, D. Latremouille-Viau, Vikash Kumar Sharma +8 more
2020Journal of Medical Economics34 citations Open access
Semantic Scholar
Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
G. Sarri, M. Bhor, S. Abogunrin, C. Farmer +3 more
2018Health and Quality of Life Outcomes25 citations Open access
Semantic Scholar
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting.
N. Dibella, D. Bhowmik, M. Bhor, M. Yap +7 more
2015Clinical Lymphoma, Myeloma & Leukemia22 citations Open access
Semantic Scholar
Everolimus vs. temsirolimus for advanced renal cell carcinoma: use and use of resources in the US Oncology Network.
N. Vogelzang, M. Bhor, Zhi-Mei Liu, R. Dhanda +1 more
2013Clinical Genitourinary Cancer22 citations
Semantic Scholar
High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study
J. Kanter, M. Bhor, Xin Li, F. Li +1 more
2019Journal of health economics and outcomes research21 citations Open access
Semantic Scholar
Obstacles and Proposed Solutions to Effective Antiretroviral Therapy in Resource-Limited Settings
J. Bartlett, J. Hornberger, A. Shewade, M. Bhor +1 more
2009Journal of the International Association of Physicians in AIDS Care17 citations Open access
Semantic Scholar
Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
Prateek Sharma, Gary W. Falk, M. Bhor, A. B. Ozbay +5 more
2023Journal of health economics and outcomes research14 citations Open access
Semantic Scholar
Real-world evidence on clinical outcomes in immune thrombocytopenia treated with thrombopoietin receptor agonists.
A. Forsythe, J. Schneider, T. Pham, M. Bhor +5 more
2020Journal of Comparative Effectiveness Research14 citations Open access
Semantic Scholar
For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports
Jason Shafrin, S. Dennen, P. Pednekar, K. Birch +3 more
2021Journal of Managed Care & Specialty Pharmacy12 citations Open access
Semantic Scholar
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
G. Tremblay, M. Dolph, M. Bhor, Q. Said +3 more
2018ClinicoEconomics and Outcomes Research11 citations Open access
Semantic Scholar
Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC).
Ian D. Schnadig, M. Bhor, N. Vogelzang, D. Hennessy +8 more
2013Journal of Clinical Oncology11 citations
Semantic Scholar
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data
K. Simpson, B. Dietz, R. Baran, K. Garren +3 more
2011Cost Effectiveness and Resource Allocation8 citations Open access
Semantic Scholar
Development and validation of a scale to assess attitudes of health care administrators toward the use of e-mail communication between patients and physicians.
M. Bhor, Holly Mason
2006Research in Social and Administrative Pharmacy8 citations
Semantic Scholar
The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US
Jason Shafrin, H. Thom, E. Keeney, D. Gaunt +5 more
2021Current Medical Research and Opinion7 citations Open access
Semantic Scholar
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
G. Tremblay, M. Dolph, M. Bhor, Q. Said +2 more
2018ClinicoEconomics and Outcomes Research7 citations Open access
Semantic Scholar
Treatment patterns and medication adherence among patients diagnosed with multiple myeloma and treated with panobinostat.
A. Chari, M. Bhor, L. Eldjerou, A. Gilligan +7 more
2018Future Oncology6 citations
Semantic Scholar
A Systematic Literature Review of the Burden of Ischemic Priapism in Patients with Sickle Cell Disease
D. Nellesen, S. Lucas, Che-Rung Liu, M. Bhor +2 more
2019Blood5 citations Open access
Semantic Scholar
Experimental Performance Evaluation of new cooling pad material for direct evaporating cooling for Pune summer conditions
M. Kulkarni, K. Vijaykumar, N. Jadhav, M. Bhor +1 more
20155 citations
Semantic Scholar
Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.
L. Doward, B. Dietz, J. Wilburn, S. McKenna +2 more
2008The AIDS reader5 citations
Semantic Scholar
Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective
G. Joseph, D. Latremouille-Viau, V. K. Sharma, P. Gagnon-Sanschagrin +7 more
2019Blood4 citations
Semantic Scholar
Health Care Resource Use (HCRU) Due To Bleeding Related Episodes (BRE) In Patients With Immune Thrombocytopenic Purpura (ITP) Receiving Eltrombopag (EPAG), Romiplostim (ROMI), Or Rituximab (RITUX): Real World Evidence (RWE) From 27 US Institutions
C. Kwon, A. Forsythe, A. Roy, M. Bhor +2 more
20174 citations Open access
Semantic Scholar
A Real-World Observational Study of Patients with Advanced Melanoma Receiving First-Line Ipilimumab in a Community Practice Setting
D. Patt, D. Rembert, M. Bhor, D. Bhowmik +1 more
20144 citations Open access
Semantic Scholar
Journal of Health Economics and Outcomes Research
Gastrointestinal Conditions, Prateek Sharma, Gary W. Falk, M. Bhor +6 more
20233 citations
Semantic Scholar
PRO3 SUCCESSOR STUDY: TREATMENT AND HEALTH CARE RESOURCE UTILIZATION BY SICKLE CELL PATIENTS WHO PARTICIPATED IN THE SUSTAIN STUDY IN THE UNITED STATES
N. Shah, R. Boccia, W. Kraft, Brandon M. Hardesty +7 more
2019Value in Health3 citations Open access
Semantic Scholar
Economic Burden of Immune Thrombocytopenia (ITP) In Patients Receiving Eltrombopag (EPAG) And Romiplostim (ROMI): Real World Evidence From 26 US Institutions
A. Forsythe, M. Bhor, A. Roy, M. S. Portella +2 more
20173 citations Open access
Semantic Scholar
Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States
Prateek Sharma, Gary W. Falk, M. Bhor, A. B. Ozbay +5 more
2023Medicine2 citations Open access
Semantic Scholar
Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study
Hyeun Ah Kang, J. Barner, Kristin M. Richards, M. Bhor +2 more
2020Journal of health economics and outcomes research2 citations
Semantic Scholar
A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists.
M. Dolph, A. Roy, M. Bhor, Jaclyn Hearnden +4 more
2018Journal of Comparative Effectiveness Research2 citations Open access
Semantic Scholar
Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI): Real World Evidence from 26 US Institutions
A. Forsythe, A. Roy, M. Bhor, M. S. Portella
20172 citations Open access
Semantic Scholar
Predictors of Emergency Room (ER) Visits and Hospitalizations in Patients with Mantle Cell Lymphoma (MCL) Treated with Chemotherapy
B. Feinberg, B. Schenkel, A. McBride, L. Ellis +3 more
20152 citations
Semantic Scholar
Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC)
I. Schnadig, M. Bhor, N. Vogelzang, D. Hennessy +8 more
20132 citations
Semantic Scholar
A systematic review to assess the burden of ischemic priapism in patients with sickle cell disease
D. Nellesen, S. Lucas, Che-Rung Liu, M. Bhor +2 more
2023Sexual Medicine Reviews1 citations
Semantic Scholar
PRO38 ASSOCIATION BETWEEN VASO-OCCLUSIVE CRISES AND OPIOID USE AMONG TEXAS MEDICAID RECIPIENTS WITH SICKLE CELL DISEASE
J. Barner, Hyeun Ah Kang, K. Richards, M. Bhor +2 more
2019Value in Health1 citations Open access
Semantic Scholar
PRO55 THE RELATIONSHIP BETWEEN VASO-OCCLUSIVE CRISES AND WORK PRODUCTIVITY IMPAIRMENT IN PATIENTS WITH SICKLE CELL DISEASE
Avery A. Rizio, M. Bhor, X. Lin, M. White +4 more
2019Value in Health1 citations Open access
Semantic Scholar
Relationship between Vaso-Occlusive Crisis and Quality of Life: An Analysis of Patients with Sickle Cell Disease in the United States
H. Thom, Jason Shafrin, E. Keeney, Lauren M Zhao +5 more
2019Blood1 citations Open access
Semantic Scholar
Comparison of Adherence, Persistence, and Bleed-Related Event Rates in Patients Diagnosed with Immune Thrombocytopenia and Treated with Thrombopoietin Receptor Agonists
D. Stafkey-Mailey, T. Lokhandwala, Q. Said, M. Bhor +1 more
20181 citations Open access
Semantic Scholar
Benefit-Risk Comparison in Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag or Romiplostim: Real World Evidence (RWE) from 26 Hospital Institutions
A. Forsythe, A. Roy, M. Bhor, A. Allepuz +3 more
20171 citations
Semantic Scholar
Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia
G. Tremblay, M. Bhor, A. Roy, B. Elliott +3 more
20171 citations
Semantic Scholar
Performance assessment of model-based SIMC for FOPDT system
R. Desai, M. Bhor, S. Admuthe
20161 citations
Semantic Scholar
Impact of number of lines of therapy following docetaxel (D) in metastatic castration-resistant prostate cancer (mCRPC).
G. Sonpavde, M. Bhor, D. Hennessy, D. Bhowmik +2 more
20141 citations
Semantic Scholar
PMH58 Impact of Positive and Negative Symptoms and Cognitive Impairment on Health Outcomes and Healt Care Resource Utilization in European Patients with Schizophrenia
N. Tundia, M. Bhor, A. Duhig, S. Hass +2 more
20121 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Paulose×12
Invite
J. Paulose — researcher profile on SciRah
N. Shah×8
Invite
N. Shah — researcher profile on SciRah
A. Roy×8
Invite
A. Roy — researcher profile on SciRah
A. Forsythe×7
Invite
A. Forsythe — researcher profile on SciRah

×7

Invite

G. Tremblay — researcher profile on SciRah

Invite

D. Bhowmik — researcher profile on SciRah

Invite

R. Halloway — researcher profile on SciRah

D. Latremouille-Viau×5

Invite

D. Latremouille-Viau — researcher profile on SciRah

M. S. Portella×5

Invite

M. S. Portella — researcher profile on SciRah

Invite

C. Kwon — researcher profile on SciRah

Invite

D. Patt — researcher profile on SciRah

S. Saravanan×4

Invite

S. Saravanan — researcher profile on SciRah